Rhine biological announced that the company's industrial hemp extraction and application project was put into operation at the site of the Indiana plant. So far, the project has been officially completed and put into trial operation. The total investment of the project is expected to reach about US $80 million, and the annual processing capacity of raw materials is expected to be 5000 tons.
Rhine biological 2021 interim report shows that the company's main revenue is 453 million yuan, a year-on-year increase of 61.36%; The net profit attributable to the parent company was 59.6256 million yuan, a year-on-year increase of 10.75%; Deduct the non net profit of 35.2283 million yuan, a year-on-year increase of 14.51%; The debt ratio is 36.12%, the investment income is 5.2142 million yuan, the financial expenses are 11.5057 million yuan, and the gross profit margin is 28.01%.
Source: Securities Star